Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: drug supply chain decentralized trials

Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience

Posted on May 15, 2025 digi By digi

Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience Bringing Clinical Trials Home: Direct-to-Patient Drug Delivery for Modern Research Direct-to-Patient (DTP) drug delivery has become a pivotal innovation in decentralized and hybrid clinical trials, enabling investigational products (IP) to reach participants directly at their homes. By minimizing site visits and enhancing patient convenience, DTP…

Read More “Direct-to-Patient Drug Delivery in Clinical Trials: Enhancing Access and Convenience” »

Decentralized Clinical Trials (DCTs), Direct-to-Patient Drug Delivery

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Impact of Phase 4 Studies on Clinical Practice Guidelines: Translating Real-World Evidence into Medical Standards
  • Phase 1 Studies for Inhaled Therapies: PK, PD, and Device Considerations
  • Decision-Making Criteria for NDA/BLA Filing After Phase 3 Trials: Key Considerations and Strategic Readiness
  • Real-World Data Integration in Phase 2 Study Planning
  • Role of Insurance Claims Data in Phase 4 Clinical Trials: Unlocking Real-World Insights

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme